Literature DB >> 17883170

Role of bone marrow trephine biopsy in the diagnosis of marrow involvement in Hodgkin's disease.

Rajiv Subramanian1, Debdatta Basu, Bhawana Badhe, Tarun K Dutta.   

Abstract

Bone marrow involvement in Hodgkin's disease alters the stage and hence the prognosis and treatment modality. Seventy-six patients of biopsy proven Hodgkin's disease in whom a bone marrow aspiration and biopsy were done simultaneously at the time of diagnosis were included in the study. Bone marrow involvement was seen in 14 (18%) cases. All 14 cases were diagnosed on biopsy. Only one aspirate was suspicious of involvement. Rest was either diluted (28%) or was normal (64%). Eleven patients were upstaged from stage I, II and III to stage IV. All patients had cytopenia of one or more cell line. Increased fibrosis, necrosis and a polymorphic cellular infiltrate were associated findings in the marrow. We wish to highlight the importance of bone marrow trephine biopsy over aspirate in staging even clinically early stage Hodgkin's disease.

Entities:  

Mesh:

Year:  2007        PMID: 17883170

Source DB:  PubMed          Journal:  Indian J Pathol Microbiol        ISSN: 0377-4929            Impact factor:   0.740


  3 in total

1.  Clinico-pathologic profile of Hodgkin's lymphoma in a rural medical college.

Authors:  Bidyut Krishna Goswami; Supriya Sarkar; Sudipta Chakrabarti; Srikrishna Mondal; Amitabha Roy; Asit R Deb
Journal:  Indian J Hematol Blood Transfus       Date:  2009-01-11       Impact factor: 0.900

2.  Efficacy and safety of bone marrow aspiration and biopsy using fluoroscopic guidance and a drill-powered needle: clinical experience from 775 cases.

Authors:  Jeremiah R Long; J Derek Stensby; Elizabeth L Wiesner; Wesley N Bryson; Travis J Hillen; Jack W Jennings
Journal:  Eur Radiol       Date:  2020-06-09       Impact factor: 5.315

3.  Clinical features of AIDS patients with Hodgkin's lymphoma with isolated bone marrow involvement: report of 12 cases at a single institution.

Authors:  Marcelo Corti; Maria Villafañe; Gonzalo Minue; Ana Campitelli; Marina Narbaitz; Leonardo Gilardi
Journal:  Cancer Biol Med       Date:  2015-03       Impact factor: 4.248

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.